Intech Investment Management LLC Sells 69,255 Shares of UnitedHealth Group Incorporated $UNH

Intech Investment Management LLC trimmed its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 25.5% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 201,959 shares of the healthcare conglomerate’s stock after selling 69,255 shares during the quarter. UnitedHealth Group makes up about 1.1% of Intech Investment Management LLC’s portfolio, making the stock its 11th biggest holding. Intech Investment Management LLC’s holdings in UnitedHealth Group were worth $105,776,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also recently bought and sold shares of the stock. Focus Partners Wealth lifted its position in shares of UnitedHealth Group by 5.3% in the first quarter. Focus Partners Wealth now owns 277,916 shares of the healthcare conglomerate’s stock valued at $145,559,000 after buying an additional 14,112 shares during the last quarter. Integrity Alliance LLC. lifted its position in shares of UnitedHealth Group by 376.4% in the first quarter. Integrity Alliance LLC. now owns 13,395 shares of the healthcare conglomerate’s stock valued at $7,016,000 after buying an additional 10,583 shares during the last quarter. Ransom Advisory Ltd acquired a new stake in shares of UnitedHealth Group in the first quarter valued at approximately $469,000. Anchor Investment Management LLC boosted its stake in UnitedHealth Group by 2.5% in the 1st quarter. Anchor Investment Management LLC now owns 23,542 shares of the healthcare conglomerate’s stock valued at $12,330,000 after purchasing an additional 570 shares during the period. Finally, Glenview Trust co boosted its stake in UnitedHealth Group by 4.6% in the 1st quarter. Glenview Trust co now owns 51,836 shares of the healthcare conglomerate’s stock valued at $27,149,000 after purchasing an additional 2,264 shares during the period. 87.86% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of analysts have recently weighed in on the company. Baird R W downgraded UnitedHealth Group from a “hold” rating to a “strong sell” rating in a research report on Thursday, July 31st. Wall Street Zen downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Saturday, May 24th. Sanford C. Bernstein upped their target price on UnitedHealth Group from $337.00 to $379.00 and gave the company an “outperform” rating in a research report on Friday, September 5th. KeyCorp cut their target price on UnitedHealth Group from $400.00 to $350.00 and set an “overweight” rating for the company in a research report on Wednesday, July 30th. Finally, TD Securities restated a “hold” rating and set a $308.00 price objective (down from $520.00) on shares of UnitedHealth Group in a research report on Monday, May 19th. Sixteen equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and three have given a Sell rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $355.77.

UnitedHealth Group Price Performance

Shares of UNH opened at $348.59 on Wednesday. UnitedHealth Group Incorporated has a 12-month low of $234.60 and a 12-month high of $630.73. The business has a 50-day simple moving average of $289.41 and a two-hundred day simple moving average of $371.39. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. The stock has a market cap of $315.71 billion, a PE ratio of 15.10, a PEG ratio of 2.09 and a beta of 0.45.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). The company had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The company’s quarterly revenue was up 12.9% on a year-over-year basis. During the same period in the previous year, the company posted $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 23rd. Investors of record on Monday, September 15th will be paid a dividend of $2.21 per share. The ex-dividend date of this dividend is Monday, September 15th. This represents a $8.84 annualized dividend and a yield of 2.5%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 38.30%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.